Eldomery, Mohammad K.
Akdemir, Zeynep C.
Vögtle, F.-Nora
Charng, Wu-Lin
Mulica, Patrycja
Rosenfeld, Jill A.
Gambin, Tomasz
Gu, Shen
Burrage, Lindsay C.
Al Shamsi, Aisha
Penney, Samantha
Jhangiani, Shalini N.
Zimmerman, Holly H.
Muzny, Donna M.
Wang, Xia
Tang, Jia
Medikonda, Ravi
Ramachandran, Prasanna V.
Wong, Lee-Jun
Boerwinkle, Eric
Gibbs, Richard A.
Eng, Christine M.
Lalani, Seema R.
Hertecant, Jozef
Rodenburg, Richard J.
Abdul-Rahman, Omar A.
Yang, Yaping
Xia, Fan
Wang, Meng C.
Lupski, James R.
Meisinger, Chris
Sutton, V. Reid
Funding for this research was provided by:
National Human Genome Research Institute (US) (U54HG006542)
Foundation for the National Institutes of Health (T32 GM07526)
Deutsche Forschungsgemeinschaft (DFG)
The Baden-Württemberg Stiftung and Emmy-Noether-Program (DFG)
CPRIT training Program (RP140102)
Prx1 antiserum